The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

Tomelleri, Alessandro; Benanti, Giovanni; Cariddi, Adriana; Calvisi, Stefania Laura; Baldissera, Elena; Boffini, Nicola; Matucci-Cerinic, Marco; Dagna, Lorenzo

Tomelleri, Alessandro; Benanti, Giovanni; Cariddi, Adriana; Calvisi, Stefania Laura; Baldissera, Elena; Boffini, Nicola; Matucci-Cerinic, Marco; Dagna, Lorenzo.

Afiliación

Tomelleri A; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Benanti G; Vita-Salute San Raffaele University, Milan, Italy.
Cariddi A; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Calvisi SL; Vita-Salute San Raffaele University, Milan, Italy.
Baldissera E; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Boffini N; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Matucci-Cerinic M; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Dagna L; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.

Rheumatology (Oxford) ; 63(2): e39-e42, 2024 Feb 01.

Article en En | MEDLINE | ID: mdl-37522875

Asunto(s)

Artritis Reumatoide; Inhibidores de las Cinasas Janus; Humanos; Inhibidores de las Cinasas Janus/uso terapéutico; Estudios Prospectivos; Quinasas Janus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Inhibidores de las Cinasas Janus Límite: Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google